Literature DB >> 19997071

Nutraceuticals and prostate cancer prevention: a current review.

Greg Trottier1, Peter J Boström, Nathan Lawrentschuk, Neil E Fleshner.   

Abstract

Nutraceuticals are 'natural' substances isolated or purified from food substances and used in a medicinal fashion. Several naturally derived food substances have been studied in prostate cancer in an attempt to identify natural preventative therapies for this disease. Vitamin E, selenium, vitamin D, green tea, soy, and lycopene have all been examined in human studies. Other potential nutraceuticals that lack human data, most notably pomegranate, might also have a preventative role in this disease. Unfortunately, most of the literature involving nutraceuticals in prostate cancer is epidemiological and retrospective. The paucity of randomized control trial evidence for the majority of these substances creates difficulty in making clinical recommendations particularly when most of the compounds have no evidence of toxicity and occur naturally. Despite these shortcomings, this area of prostate cancer prevention is still under intense investigation. We believe many of these 'natural' compounds have therapeutic potential and anticipate future studies will consist of well-designed clinical trials assessing combinations of compounds concurrently.

Entities:  

Mesh:

Year:  2009        PMID: 19997071     DOI: 10.1038/nrurol.2009.234

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  98 in total

1.  A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma.

Authors:  Aminah Jatoi; Neil Ellison; Patrick A Burch; Jeff A Sloan; Shaker R Dakhil; Paul Novotny; Winston Tan; Tom R Fitch; Kendrith M Rowland; Charles Y F Young; Patrick J Flynn
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

2.  Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis.

Authors:  R K Nam; N Fleshner; E Rakovitch; L Klotz; J Trachtenberg; R Choo; G Morton; C Danjoux
Journal:  J Urol       Date:  1999-05       Impact factor: 7.450

3.  Intensive lifestyle changes may affect the progression of prostate cancer.

Authors:  Dean Ornish; Gerdi Weidner; William R Fair; Ruth Marlin; Elaine B Pettengill; Caren J Raisin; Stacey Dunn-Emke; Lila Crutchfield; F Nicholas Jacobs; R James Barnard; William J Aronson; Patricia McCormac; Damien J McKnight; Jordan D Fein; Ann M Dnistrian; Jeanmaire Weinstein; Tung H Ngo; Nancy R Mendell; Peter R Carroll
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

4.  A prospective clinical trial of green tea for hormone refractory prostate cancer: an evaluation of the complementary/alternative therapy approach.

Authors:  E Choan; Roanne Segal; Derek Jonker; Shawn Malone; Neil Reaume; Libni Eapen; Victor Gallant
Journal:  Urol Oncol       Date:  2005 Mar-Apr       Impact factor: 3.498

5.  Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

Authors:  Saverio Bettuzzi; Maurizio Brausi; Federica Rizzi; Giovanni Castagnetti; Giancarlo Peracchia; Arnaldo Corti
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

6.  Intake of carotenoids and retinol in relation to risk of prostate cancer.

Authors:  E Giovannucci; A Ascherio; E B Rimm; M J Stampfer; G A Colditz; W C Willett
Journal:  J Natl Cancer Inst       Date:  1995-12-06       Impact factor: 13.506

Review 7.  Chemoprevention of prostate cancer: what can be recommended to patients?

Authors:  Janet L Colli; Christopher L Amling
Journal:  Curr Urol Rep       Date:  2009-05       Impact factor: 3.092

8.  Lycopene: a novel drug therapy in hormone refractory metastatic prostate cancer.

Authors:  M S Ansari; N P Gupta
Journal:  Urol Oncol       Date:  2004 Sep-Oct       Impact factor: 3.498

9.  Uptake of lycopene and its geometrical isomers is greater from heat-processed than from unprocessed tomato juice in humans.

Authors:  W Stahl; H Sies
Journal:  J Nutr       Date:  1992-11       Impact factor: 4.798

10.  Lycopene for advanced hormone refractory prostate cancer: a prospective, open phase II pilot study.

Authors:  Carla Schwenke; Burkhard Ubrig; Petra Thürmann; Christian Eggersmann; Stephan Roth
Journal:  J Urol       Date:  2009-01-15       Impact factor: 7.450

View more
  24 in total

1.  Consumption of soy isoflavone enriched bread in men with prostate cancer is associated with reduced proinflammatory cytokines and immunosuppressive cells.

Authors:  Gregory B Lesinski; Patrick K Reville; Thomas A Mace; Gregory S Young; Jennifer Ahn-Jarvis; Jennifer Thomas-Ahner; Yael Vodovotz; Zeenath Ameen; Elizabeth Grainger; Kenneth Riedl; Steven Schwartz; Steven K Clinton
Journal:  Cancer Prev Res (Phila)       Date:  2015-08-14

2.  Upsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapy.

Authors:  Subash C Gupta; David Hevia; Sridevi Patchva; Byoungduck Park; Wonil Koh; Bharat B Aggarwal
Journal:  Antioxid Redox Signal       Date:  2012-01-16       Impact factor: 8.401

3.  Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.

Authors:  Sophia L Maund; Wendy W Barclay; Laura D Hover; Linara S Axanova; Guangchao Sui; Jason D Hipp; James C Fleet; Andrew Thorburn; Scott D Cramer
Journal:  Cancer Res       Date:  2011-06-08       Impact factor: 12.701

4.  Prevention strategies in prostate cancer.

Authors:  Greg Trottier; N Lawrentschuk; N E Fleshner
Journal:  Curr Oncol       Date:  2010-09       Impact factor: 3.677

5.  Role of E-cadherin in antimigratory and antiinvasive efficacy of silibinin in prostate cancer cells.

Authors:  Gagan Deep; Subhash Chander Gangar; Chapla Agarwal; Rajesh Agarwal
Journal:  Cancer Prev Res (Phila)       Date:  2011-05-05

Review 6.  Antimetastatic efficacy of silibinin: molecular mechanisms and therapeutic potential against cancer.

Authors:  Gagan Deep; Rajesh Agarwal
Journal:  Cancer Metastasis Rev       Date:  2010-09       Impact factor: 9.264

7.  Sprouty2, PTEN, and PP2A interact to regulate prostate cancer progression.

Authors:  Rachana Patel; Meiling Gao; Imran Ahmad; Janis Fleming; Lukram B Singh; Taranjit Singh Rai; Arthur B McKie; Morag Seywright; Robert J Barnetson; Joanne Edwards; Owen J Sansom; Hing Y Leung
Journal:  J Clin Invest       Date:  2013-02-22       Impact factor: 14.808

8.  A possible predictive marker of progression for hepatocellular carcinoma.

Authors:  Michele DI Stasio; Maria Grazia Volpe; Giovanni Colonna; Melissa Nazzaro; Miriam Polimeno; Stefania Scala; Giuseppe Castello; Susan Costantini
Journal:  Oncol Lett       Date:  2011-08-09       Impact factor: 2.967

Review 9.  Plants vs. cancer: a review on natural phytochemicals in preventing and treating cancers and their druggability.

Authors:  Hu Wang; Tin Oo Khor; Limin Shu; Zheng-Yuan Su; Francisco Fuentes; Jong-Hun Lee; Ah-Ng Tony Kong
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

10.  Current concepts and prospects of herbal nutraceutical: A review.

Authors:  Baby Chauhan; Gopal Kumar; Nazia Kalam; Shahid H Ansari
Journal:  J Adv Pharm Technol Res       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.